Xenon Pharmaceuticals Inc.
XENE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $2,471,243 | $2,639,966 | $3,072,756 |
| - Cash | $104,514 | $135,381 | $116,657 | $142,712 |
| + Debt | $6,832 | $8,715 | $8,675 | $9,015 |
| Enterprise Value | – | $2,344,577 | $2,531,984 | $2,939,059 |
| Revenue | $0 | $0 | $7,500 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$77,054 | -$632 | $7,500 | $0 |
| % Margin | – | – | 100% | – |
| EBITDA | -$89,578 | -$93,597 | -$72,079 | -$76,844 |
| % Margin | – | – | -961.1% | – |
| Net Income | -$90,896 | -$84,706 | -$65,047 | -$65,685 |
| % Margin | – | – | -867.3% | – |
| EPS Diluted | -1.15 | -1.07 | -0.83 | -0.84 |
| % Growth | -7.5% | -28.9% | 1.2% | – |
| Operating Cash Flow | -$71,752 | -$64,233 | -$61,652 | -$54,385 |
| Capital Expenditures | -$281 | -$157 | -$43 | -$783 |
| Free Cash Flow | -$72,033 | -$64,390 | -$61,695 | -$55,168 |